Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2629 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bicycle Therapeutics Ltd.. (12/15/16). "Press Release: Cancer Research UK and Bicycle Therapeutics Collaborate to Trial New Therapy for Advanced Solid Tumours". London, Cambridge & Cambridge, MA. 2016-12-15
Microsaic Systems plc. (12/13/16). "Press Release: Trading Update". 2016-12-13
Oxford Nanopore Technologies Ltd.. (12/12/16). "Press Release: Oxford Nanopore Announces £100M / $126M Fundraising". Oxford. 2016-12-12
AstraZeneca plc. (12/9/16). "Press Release: US FDA Accepts First Biologics License Application for AstraZeneca’s Durvalumab in Bladder Cancer". 2016-12-09
AstraZeneca plc. (12/9/16). "Press Release: AstraZeneca and Lilly to Develop Second Potentially Disease-modifying Treatment for Alzheimer’s Disease". 2016-12-09
Inflazome Ltd.. (9/12/16). "Press Release: Inflazome Closes Series A Financing". Dublin. 2016-12-09
Heptares Therapeutics Ltd.. (12/8/16). "Press Release: Heptares Scientists Solve Structure of CCR9 Chemokine Receptor Offering Unique Opportunity to Apply Structure-Based Design across Chemokine Receptor Family". London. 2016-12-08
AstraZeneca plc. (12/6/16). "Press Release: Tagrisso Demonstrates Superiority over Chemotherapy in EGFR T790M Mutation-positive Non-small Cell Lung Cancer". 2016-12-06
AstraZeneca plc. (12/5/16). "Press Release: AstraZeneca Completes Agreement With Cilag GmbH International for Rights to Rhinocort Aqua Outside the US". 2016-12-05
Kymab Group Ltd.. (12/5/16). "Press Release: Antibody Shows Dramatic Post-transplant Benefit". 2016-12-05
F2G Ltd.. (12/5/16). "Press Release: F2G Ltd Announces the Appointment of John H. Rex, MD, FACP to the Position of Chief Medical Officer". Manchester. 2016-12-05
Takeda Pharmaceutical Co. Ltd.. (12/2/16). "Press Release: Cerevance Launched with New Technology, Drug Portfolio and $36m in Cash to Tackle Brain Diseases". Osaka & Cambridge, MA. 2016-12-02
Bellevue Group AG. (12/2/16). "Press Release: Successful Launch of BB Healthcare Trust plc on the London Stock Exchange – Initial Issue Volume GBP 150 Million [Not for US]". 2016-12-02
Bicycle Therapeutics Ltd.. (12/1/16). "Press Release: Bicycle Therapeutics Announces Broad Partnership with AstraZeneca to Develop Bicyclic Peptides (Bicycles)". Cambridge & Cambridge, MA. 2016-12-01
Genomics plc. (12/1/16). "Press Release: Wellcome Trust Centre for Human Genetics and Genomics plc First to Sequence Multiple Human Genomes Using Hand-held Nanopore Technology". Oxford. 2016-12-01
Congenica Ltd.. (12/1/16). "Press Release: Elucigene Partners with Congenica on New NGS Cystic Fibrosis Kit". 2016-12-01
Coulter Partners. (12/1/16). "Press Release: Coulter Partners Places Chief Financial Officer for Medigene AG". 2016-12-01
Heptares Therapeutics Ltd.. (11/30/16). "Press Release: Heptares to Acquire G7 Therapeutics to Extend Leadership in GPCR-Focused Drug Discovery and Development". London & Zurich. 2016-11-30
John Wiley & Sons. (11/30/16). "Press Release: Wiley Launches New Spectra Lab Applications to Help Scientists Manage Analytical Data". 2016-11-30
Orchard Therapeutics Ltd.. (11/29/16). "Press Release: Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica". London & Oxford. 2016-11-29
International Phenome Centre Network (IPCN). (11/29/16). "Press Release: Global Research Network Hunts the Missing Link between Genetics and Environmental Factors to Unlock the Secrets of Global Diseases such as Cancer and Diabetes to Revolutionise Healt 2016-11-29
AstraZeneca plc. (11/29/16). "Press Release: AstraZeneca Takes Latest Scientific Advances in Oncology to Major US and European Congresses". 2016-11-29
Bicycle Therapeutics Ltd.. (11/28/16). "Press Release: Bicycle Therapeutics to Present Preclinical Data at the 28th EORTC-NIC-AACR Molecular Targets and Cancer Therapeutics Symposium". Cambridge, MA & Cambridge. 2016-11-28
GlaxoSmithKline plc. (11/25/16). "Press Release: GSK Announces EU Regulatory Submission of Candidate Vaccine for Prevention of Shingles – Follows Regulatory Submissions in US and Canada". London. 2016-11-25
GHO Capital Partners LLP. (11/25/16). "Press Release: GHO Capital Closes €660 Million Private Equity Fund". London. 2016-11-25
Kymab Group Ltd.. (11/24/16). "Press Release: Kymab Secures US$100 Million Series C Funding". 2016-11-24
GlaxoSmithKline plc. (11/24/16). "Press Release: GSK Starts Phase III Programme with Daprodustat for Anaemia Associated with Chronic Kidney Disease". London. 2016-11-24
LIFNano Therapeutics Ltd.. (11/24/16). "Press Release: Innovative Multiple Sclerosis Treatment Receives £1m Funding Boost". 2016-11-24
GlaxoSmithKline plc. (11/23/16). "Press Release: GSK Announces Phase lll Study of Mepolizumab Meets Co-primary Endpoints and All Secondary Endpoints in Patients with Eosinophilic Granulomatosis with Polyangiitis". London. 2016-11-23
Medtech Accelerator. (11/23/16). "Press Release: Medtech Accelerator Finance Scheme Introduced in a £1.5 Million Joint Venture". 2016-11-23
Avacta Group plc. (11/23/16). "Press Release: Avacta Demonstrates Key Performance Benefits of Affimer Technology for Affinity Separation". 2016-11-23
Orchard Therapeutics Ltd.. (11/23/16). "Press Release: Orchard Therapeutics and UCLA Receive USD20 Million in Latest Round of Funding from California’s Stem Cell Agency". London. 2016-11-23
Malvern Instruments Ltd.. (11/22/16). "Press Release: Malvern and PANalytical Announce Merger". 2016-11-22
Autolus Therapeutics Ltd.. (11/22/16). "Press Release: Autolus to Manufacture at the Cell and Gene Therapy Catapult – Collaboration to Support GMP Approval and Licensure of the Centre". London. 2016-11-22
GlaxoSmithKline plc. (11/21/16). "Press Release: GSK Files Regulatory Submission in US for Once-daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD". London. 2016-11-21
Sanger Institute. (11/21/16). "Press Release: Prime Minister Opened £42m Biodata Innovation Centre and New Sequencing Facility". 2016-11-21
Horizon Discovery Group plc. (11/17/16). "Press Release: Horizon Discovery Partners with Sophia Genetics on NGS Reference Standards for Oncology Applications". Lausanne & Cambridge. 2016-11-17
Horizon Discovery Group plc. (11/16/16). "Press Release: Horizon Discovery Enters Chinese Clinical Diagnostics Market". Cambridge. 2016-11-16
Evotec AG. (11/14/16). "Press Release: Evotec to Present at Two Upcoming IR Conferences in November". Hamburg. 2016-11-14
Evotec AG. (11/10/16). "Press Release: Evotec and Oxford Create Novel Partnership Called »LAB282«". Hamburg. 2016-11-10
Sartorius AG. (11/10/16). "Press Release: Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory in Boston". Göttingen & Boston, MA. 2016-11-10
Adaptimmune Therapeutics plc. (11/10/16). "Press Release: Adaptimmune Reports Third Quarter 2016 Financial Results". Philadeliphia, PA & Oxford. 2016-11-10
Enterprise Therapeutics Ltd.. (11/10/16). "Press Release: Enterprise Therapeutics Announces £4 million ($5 million USD) Fundraising". Brighton. 2016-11-10
Almac Group Ltd.. (11/10/16). "Press Release: Almac Group Announce £27 million Global Expansion. Global Headcount Set to Reach 5,000 by 2017". Craigavon. 2016-11-10
Affimed N.V.. (11/9/16). "Press Release: Affimed to Present at the Jefferies 2016 London Healthcare Conference". Heidelberg. 2016-11-09
Tecan Group Ltd.. (11/9/16). "Press Release: Tecan to Present at Jefferies 2016 London Healthcare Conference". Männedorf. 2016-11-09
Horizon Discovery Group plc. (11/9/16). "Press Release: Horizon Discovery and CareDx Enter into OEM Agreement for Routine Inclusion of Cell-Free DNA Reference Standards in Transplant Testing". Cambridge. 2016-11-09
Ablynx N.V.. (11/9/16). "Press Release: Ablynx to Present at the Jefferies London Healthcare Conference 2016". Ghent. 2016-11-09
Oxford Nanopore Technologies Ltd.. (11/3/16). "Press Release: Oxford Nanopore Responds to the Patent Lawsuit Filed by Pacific Biosciences". 2016-11-03
Neovacs S.A.. (11/3/16). "Press Release: Neovacs to Attend Jefferies 2016 London Healthcare Conference November 16 & 17, 2016". Paris & Boston, MA. 2016-11-03
Bruker Corporation. (11/2/16). "Press Release: Bruker Announces Acquisition of Nucleic Acid Testing (NAT) Assays and Syndromic Panel Technology to Expand its MALDI Biotyper Platform". Billerica. 2016-11-02
Owlstone Medical. (11/1/16). "Press Release: Owlstone Medical and Imperial College Collaborate to Study Underlying Causes of Asthma Exacerbations". Cambridge. 2016-11-01
Bruker Corporation. (11/1/16). "Press Release: Bruker Bio AFM Enables Advanced DNA Research at University of Leeds". Santa Barbara, CA. 2016-11-01
Proteome Sciences plc. (10/31/16). "Press Release: Placing and Subscription of 66,258,100 New Ordinary Shares at 5 Pence perShare and Notice of General Meeting". 2016-10-31
Arix Bioscience plc. (10/31/16). "Press Release: Arix Bioscience Appoints Dr Franz B. Humer as Senior Independent Director". London. 2016-10-31
Freshfields Bruckhaus Deringer. (10/28/16). "Pressemitteilung: Krebstherapie – Freshfields berät Ganymed-Eigner beim Verkauf an Astellas Pharma". 2016-10-28
Freshfields Bruckhaus Deringer. (10/28/16). "Pressemitteilung: Freshfields berät Mologen AG bei Bezugsrechtskapitalerhöhung und Emission einer Wandelschuldverschreibung". 2016-10-28
Mercia Technologies plc. (10/27/16). "Press Release: Investment in Oxford Genetics Limited". 2016-10-27
AB Sciex (d/b/a Sciex). (10/27/16). "Press Release: Scientists Eradicate Leukemic Stem Cells by Targeting Cell Survival Proteins. Sciex Mass Spectrometry-based Solutions Lead to Leukemia Breakthroughs". Framingham, MA. 2016-10-27
Probiodrug AG. (10/27/16). "Press Release: Probiodrug to Present at European Life Sciences Conferences. Attendance at Key Conferences in November 2016". Halle (Saale). 2016-10-27
Genomics Medicine Ireland Ltd.. (10/26/16). "Press Release: Genomics Medicine Ireland Raises $40 Million in Series A Funding". Dublin. 2016-10-26
Eurofins Scientific UK. (10/24/16). "Press Release: Eurofins Acquires International Laboratory Services Ltd". 2016-10-24
Mundipharma International Ltd.. (10/19/16). "Press Release: Results from the NOR-SWITCH Study Support Switch from Remicade to Remsima (biosimilar infliximab)". Cambridge. 2016-10-19
Markes International Ltd.. (10/18/16). "Press Release: Markes International Enhances Its Suite of Thermal Desorption Products with New Sorptive Extraction Technology". Llantrisant. 2016-10-18
Jefferies Group LLC. (10/18/16). "Press Release: Jefferies to Host 2016 London Healthcare Conference". London. 2016-10-18
Arquer Diagnostics Ltd.. (10/18/16). "Press Release: Arquer Diagnostics and the University of Sunderland Collaborate to Extend Application of Cancer Diagnostic". Sunderland. 2016-10-18
Arquer Diagnostics Ltd.. (10/18/16). "Press Release: Arquer Diagnostics Appoints Nadia Whittley as CEO". Sunderland. 2016-10-18
Ergomed plc. (10/14/16). "Press Release: Ergomed’s Co-development Partner Aeterna Zentaris, Inc. Announces a Fourth Licensing Agreement for Zoptrex". London. 2016-10-14
PhoreMost Ltd.. (10/12/16). "Press Release: PhoreMost Ltd and University of Cambridge Collaborate to Identify Innovative Drug Targets for Neurodegenerative Disease". Cambridge. 2016-10-12
Immunocore Ltd.. (10/12/16). "Press Release: Immunocore Appoints Paul Fry as Chief Financial Officer". Oxford. 2016-10-12
Oxford Immunotec Global plc. (10/12/16). "Press Release: Oxford Immunotec Acquires Immunetics, Inc.". Oxford & Marlborough, MA. 2016-10-12
Adaptimmune Therapeutics plc. (10/12/16). "Press Release: Adaptimmune Provides Update on Clinical Study Evaluating Its SPEAR T-Cell Therapy Targeting NY-ESO-1 in Ovarian Cancer". Philadeliphia, PA & Oxford. 2016-10-12
Midatech Pharma plc. (10/11/16). "Press Release: Results of Placing to raise £16.0 million and PDMR Shareholding [Not for United States, Canada, Australia, South Africa, Japan, New Zealand, et al.]". 2016-10-11
Kymab Ltd.. (10/11/16). "Press Release: Bispecific Antibody Agreement with EpimAb". 2016-10-11
Arcis Biotechnology Ltd.. (10/11/16). "Press Release: Arcis Biotechnology Launches IVD for the Preparation of DNA from Blood". Daresbury. 2016-10-11
Crescendo Biologics Ltd.. (10/10/16). "Press Release: Crescendo Biologics and Takeda Enter Collaboration for Humabody-based Therapeutics Worth up to $790m". Cambridge & Osaka. 2016-10-10
Malin Corporation plc. (10/7/16). "Press Release: Malin Corporation plc Appoints Peter Schwartzman to Senior Management Team". Dublin. 2016-10-07
Syncona LLP. (10/5/16). "Press Release: Achilles Therapeutics Launched with Funds of £13.2 Million to Develop Immunotherapies for Cancer". 2016-10-05
Owlstone Medical. (10/4/16). "Press Release: Owlstone Medical Receives CE Mark Approval for Pediatric Disease Breathalyzer". Cambridge. 2016-10-04
Healx Ltd.. (10/4/16). "Press Release: Healx Announces £1.5m Investment Led by Jonathan Milner". 2016-10-04
Carrick Therapeutics Ltd.. (10/3/16). "Press Release: Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies. $95m Initial Funding from Leading Investor Syndicate". Dublin. 2016-10-03
ReViral Ltd.. (10/3/16). "Press Release: ReViral Announces Appointment of New Chief Executive Officer". London. 2016-10-03
Prothena Corporation plc. (10/3/16). "Press Release: Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director". Dublin. 2016-10-03
AstraZeneca plc. (9/30/16). "Press Release: AstraZeneca Presents New Data on Faslodex in Breast Cancer and Provides Immuno-oncology Update at ESMO 2016 Congress". 2016-09-30
DNA Electronics Ltd.. (9/30/16). "Press Release: BARDA Awards $51.9 Million Contract to DNAe to Develop Semiconductor DNA Sequencing Platform for Rapid Diagnosis of Antimicrobial Resistant Infections and Influenza". London & Carlsbad, CA. 2016-09-30
GlaxoSmithKline plc. (9/29/16). "Press Release: GlaxoSmithKline plc Appoints Brian McNamara as CEO of GSK Consumer Healthcare". London. 2016-09-29
Atlantic Healthcare plc. (9/29/16). "Press Release: Atlantic Healthcare Appoints Karl Keegan as Chief Financial Officer". Cambridge & Raleigh, NC. 2016-09-29
AstraZeneca plc. (9/28/16). "Press Release: AstraZeneca Appoints David Goldstein as Chief Adviser for Its Genomics Initiative". 2016-09-28
GlaxoSmithKline plc. (9/28/16). "Press Release: GlaxoSmithKline Announces Intention to Sell Remaining Holding in Aspen". London. 2016-09-28
GlaxoSmithKline plc. (9/28/16). "Press Release: GlaxoSmithKline Completes Sale of Remaining Aspen Shares". London. 2016-09-28
Microsaic Systems plc. (9/28/16). "Press Release: Retirement of Chairman". 2016-09-28
Adaptimmune Therapeutics plc. (9/26/16). "Press Release: MD Anderson Cancer Center and Adaptimmune Form Strategic Alliance to Advance Development of Immunotherapies Targeting Multiple Cancers". Philadeliphia, PA, Houston, TX & Oxford. 2016-09-26
Ergomed plc. (9/26/16). "Press Release: Unaudited Interim Results for the Six Months ended 30 June 2016". Guildford. 2016-09-26
Genomics England Ltd.. (9/23/16). "Press Release: GenomOncology’s Knowledge Management System to Analyse Cancer Samples in the 100,0000 Genomes Project". 2016-09-23
Ergomed plc. (9/22/16). "Press Release: Ergomed’s Full Service Contract Win Validates Strategic Rationale of Recent Acquisitions". London. 2016-09-22
Owlstone Medical. (9/22/16). "Press Release: Owlstone Medical Commences Next Phase in World’s Largest Breath-based Clinical Trial for Early Cancer Detection". Cambridge. 2016-09-22
Sygnis AG. (9/22/16). "Press Release: Sygnis AG Enters into Collaboration Agreement with ECACC for Licensing and Distribution of Caco-2 Cell Line". Madrid & Heidelberg. 2016-09-22
Proteome Sciences plc. (9/22/16). "Press Release: Study Demonstrates Mass Spectrometry Technique Dramatically Enhances Detection of Key Early Stage Alzheimer's Biomarkers. Publication: Journal of Alzheimer's disease". Cobham. 2016-09-22
Artios Pharma Ltd.. (9/21/16). "Press Release: Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies". Cambridge. 2016-09-21
Imperial Innovations Group plc. (9/21/16). "Press Release: Innovations Invests £5.1m in Artios Pharma Limited". 2016-09-21
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top